Education
About Us
Working with TipRanks
Follow Us
Axsome Therapeutics Inc (AXSM)
NASDAQ:AXSM
AXSM Analyst Ratings
Strong Buy
17 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
AXSM Stock 12 Month Forecast
Average Price Target
$174.14
▲(61.41% Upside)
| Highest Price Target$216.00 | Average Price Target$174.14 | Lowest Price Target$133.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
RBC Capital
Reiterated
04/03/25
H.C. Wainwright
Reiterated
04/03/25
Guggenheim
Reiterated
04/01/25
William Blair
Reiterated
04/01/25
Leerink Partners
Reiterated
04/01/25
Bank of America Securities
Reiterated
04/01/25
Needham
Reiterated
04/01/25
Morgan Stanley
Reiterated
04/01/25
Mizuho Securities
Reiterated
04/01/25
Truist Financial
Reiterated
03/26/25
Piper Sandler
$148
Buy
37.18%
Upside
Reiterated
03/26/25
Piper Sandler Sticks to Their Buy Rating for Axsome Therapeutics (AXSM)
Wells Fargo
$160
Buy
48.30%
Upside
Reiterated
03/25/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: Roche Holding AG (Other OTC: RHHVF), Kezar Life Sciences (NASDAQ: KZR) and Axsome Therapeutics (NASDAQ: AXSM)
TD Cowen
$190
Buy
76.11%
Upside
Reiterated
03/06/25
TD Cowen Reaffirms Their Buy Rating on Axsome Therapeutics (AXSM)
Robert W. Baird
$132→$160
Buy
48.30%
Upside
Reiterated
03/03/25
Axsome Therapeutics price target raised to $160 from $132 at BairdAxsome Therapeutics price target raised to $160 from $132 at Baird
Cantor Fitzgerald
$124→$153
Buy
41.81%
Upside
Reiterated
02/18/25
Cantor Fitzgerald Reaffirms Their Buy Rating on Axsome Therapeutics (AXSM)
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
RBC Capital
Reiterated
04/03/25
H.C. Wainwright
Reiterated
04/03/25
Guggenheim
Reiterated
04/01/25
William Blair
Reiterated
04/01/25
Leerink Partners
Reiterated
04/01/25
Bank of America Securities
Reiterated
04/01/25
Needham
Reiterated
04/01/25
Morgan Stanley
Reiterated
04/01/25
Mizuho Securities
Reiterated
04/01/25
Truist Financial
Reiterated
03/26/25
Piper Sandler
$148
Buy
37.18%
Upside
Reiterated
03/26/25
Piper Sandler Sticks to Their Buy Rating for Axsome Therapeutics (AXSM)
Wells Fargo
$160
Buy
48.30%
Upside
Reiterated
03/25/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: Roche Holding AG (Other OTC: RHHVF), Kezar Life Sciences (NASDAQ: KZR) and Axsome Therapeutics (NASDAQ: AXSM)
TD Cowen
$190
Buy
76.11%
Upside
Reiterated
03/06/25
TD Cowen Reaffirms Their Buy Rating on Axsome Therapeutics (AXSM)
Robert W. Baird
$132→$160
Buy
48.30%
Upside
Reiterated
03/03/25
Axsome Therapeutics price target raised to $160 from $132 at BairdAxsome Therapeutics price target raised to $160 from $132 at Baird
Cantor Fitzgerald
$124→$153
Buy
41.81%
Upside
Reiterated
02/18/25
Cantor Fitzgerald Reaffirms Their Buy Rating on Axsome Therapeutics (AXSM)
AXSM Analyst Recommendation Trends
Rating
Dec 24
Jan 25
Feb 25
Mar 25
Apr 25
Strong Buy
13
16
19
20
20
Buy
42
48
55
60
49
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
55
64
74
80
69
Each month's total comprises the sum of three months' worth of ratings.
AXSM Financial Forecast
AXSM Stock Forecast FAQ
What is AXSM’s average 12-month price target, according to analysts?
Based on analyst ratings, Axsome Therapeutics Inc’s 12-month average price target is $174.14.
What is AXSM’s upside potential, based on the analysts’ average price target?
Axsome Therapeutics Inc has 61.41% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is AXSM a Buy, Sell or Hold?
Axsome Therapeutics Inc has a consensus rating of Strong Buy which is based on 17 buy ratings, 0 hold ratings and 0 sell ratings.
What is Axsome Therapeutics Inc’s price target?
The average price target for Axsome Therapeutics Inc is $174.14. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $216.00 ,the lowest forecast is $133.00. The average price target represents 61.41% Increase from the current price of $107.89.
The highest analyst price target is $216.00 ,the lowest forecast is $133.00. The average price target represents 61.41% Increase from the current price of $107.89.
What do analysts say about Axsome Therapeutics Inc?
Axsome Therapeutics Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 17 Wall Streets Analysts.
How can I buy shares of AXSM?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.